LOGIN  |  REGISTER
Astria Therapeutics
Recursion

Presenting on the Emerging Growth Conference on April 19 Register Now

April 18, 2023 | Last Trade: C$0.15 0.02 15.38

MIAMI, April 18, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 54th Emerging Growth Conference on April 19, 2023.

The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

Register for the conference here.

Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.

April 19, 2023, Schedule: (Eastern Time)

For updates, follow us on Twitter

8:30
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.

9:00
Introduction

9:05 - 9:35
Ur-Energy (NYSE American: URG) (TSX: URE)
John W. Cash, CEO

9:40 - 10:10
Houston Natural Resources Corp. (OTC Pink: HNRC)
Frank Kristan, Chairman & CEO

10:15 - 10:45
RDARS, Inc. (OTCQB: RDRSF) (CSE: RDRS)
Charles Zwebner, CEO

10:50 - 11:20
ASP Isotopes, Inc. (NASDAQ: ASPI)
Paul Elliot Mann, CEO & Chairman

12:35 - 1:05
NanoXplore, INc. (OTCQX: NNXPF) (TSX: GRA)
Martin Gagne / Director of Investor Relations

1:10 - 1:40
Rakovina Therapeutics, Inc., (TSXV: RKV)
Mr. Jeffrey, Executive Chairman

1:45 - 2:15
DSS, Inc. (NYSE American: DSS)
Jason Grady, COO

2:20 - 2:50
The OLB Group, Inc. (NASDAQ: OLB)
Ronny, Yakov, President / CEO & Patrick Smith, Vice President

Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

Register for the conference here.

Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.

Replays: subscribe to our YouTube Channel

About EmergingGrowth.com

Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

About the Emerging Growth Conference

The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

If you believe or know of a company that might fit our audience, contact us here.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.

Contact:

Emerging Growth
Phone: 1-305-330-1985
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Terns Pharmaceuticals

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB